Safety and efficacy outcomes of the Xen45 Gel Stent use for refractory glaucoma: a surgery series from surgeon trainees at a tertiary teaching hospital

Safety and efficacy outcomes of the Xen45 Gel Stent use for refractory glaucoma: a surgery series from surgeon trainees at a tertiary teaching hospital

Abstract Background To study the effect of an ab interno gelatin stent (XEN45 Gel Stent, Allergan Inc., Irvine, California, USA) on intraocular pressure (IOP) as placed by glaucoma fellowship trainees in eyes with refractory glaucoma. Methods A prospective noncomparative study at a tertiary training...

Full description

Bibliographic Details
Main Authors: Karen Hong, John Lind, Arsham Sheybani
Format: Article
Language:English
Published: BMC 2020-02-01
Series:Eye and Vision
Subjects:
XEN
Investigational devices
Glaucoma
Gelatin stent
Ab interno surgery
Minimally invasive glaucoma surgery
Online Access:https://doi.org/10.1186/s40662-019-0171-0

Internet

https://doi.org/10.1186/s40662-019-0171-0

Similar Items